Psychiatric Drug Facts via breggin.com :

“Most psychiatric drugs can cause withdrawal reactions, sometimes including life-threatening emotional and physical withdrawal problems… Withdrawal from psychiatric drugs should be done carefully under experienced clinical supervision.” Dr. Peter Breggin

Apr 9, 2012

Eugenics: Lundbeck Foundation’s Initiative for Integrative Psychiatric Research (iPSYCH)

first published March 27, 2012 "The Lundbeck Foundation’s Initiative for Integrative Psychiatric Research (iPSYCH)" Updated April 9, 2012 
neuropsychopharmacological scam
Apparently, 'the causes' are assumed to be biological in nature---ethical scientific research into the cause of a phenomena does not ASSUME anything; nor does it presume to determine what the outcome will be.  e.g. "We will identify biological disease mechanisms"  How long have psychiatric researchers been saying that?  Lundbeck is obviously desperate to continue to drug people with psychiatric diagnosis---in order to do so, they are desperate to find the thus far, elusive mythological 'diseases' which cause the 'mental illnesses' they have been claiming to 'treat' for decades...


via The Lundbeck Foundation:
19.03.2012


Record-breaking grant: New research project to investigate the causes of mental disorders


Is it possible to prevent the development of schizophrenia? Can certain patients develop autism if they carry a specific gene and have been exposed to a viral fetal infection? Should all ADHD patients take the same type of medication?

This unique research project will try to answer these questions. The project is based at Aarhus University and will be known as ‘The Lundbeck Foundation’s Initiative for Integrative Psychiatric Research’ (iPSYCH). The grant of DKK 121 million from the Lundbeck Foundation is the largest grant ever awarded to Danish psychiatric research.

”We will investigate why some people develop mental disorders. We will identify biological disease mechanisms, and we also intend to provide the basis for better treatment and prevention”, says Dr. Børglum, Professor of Medical Genetics at Aarhus University and Scientific Director of the research project. 

The many faces of psychiatry
The project will study five specific mental disorders: schizophrenia, manic depression, depression, autism and ADHD. All disorders are associated with major human and societal costs all over the world. The new thing is that researchers will study these disorders from many different angles, ranging from genes and cells to population studies, from fetus to adult, from cause to symptoms of the disorder, and this knowledge will be combined in new ways across scientific fields. 

“People suffering from a mental disorder such as schizophrenia may have very different lives: a family life with children and a job – or a life characterized by chronic disease and homelessness. The disorders do not affect all patients in exactly the same way. We do not know why, but we do know that our current treatment methods are far from optimal because we need more knowledge about the causes behind the disorders, but also about the differences in the development”, says Dr. Børglum.

”Our main goal is to identify the causes of these disorders by studying the interplay between genetic and environmental factors and thereby find new targets for treatment. The perspective is to offer better and individualized treatment, providing a better life for each individual patient with the disorder – and perhaps even ways to prevent the development of the disorder in some cases”, he says.

Professor Mikael Rørth, Chairman of the Board of Trustees of the Lundbeck Foundation, is pleased with the research opportunities that the new grant will offer:
”Mental disorders are determined by a combination of genetic and psycho-social factors. The research project will combine unique Danish registers and biobanks and is expected to pave the way for better treatment in the future”, says Dr. Rørth.
International collaboration

iPSYCH consists of leading researchers within psychiatry, genetics and register-based research. The team collaborates with e.g. the SSI (Statens Serum Institut) under the Danish Ministry of Health, Beijing Genomics Institute (BGI), deCode Genetics in Iceland and the Genetic Biobank of the Faroe Islands. In combination, this will provide unique opportunities for creating ground breaking new knowledge, which may result in better and more individualized treatment of patients by considering genetic profile, environmental factors and clinical symptoms in combination.

The iPSYCH project team consists of the following researchers:
Professor Anders Børglum, Aarhus University and Aarhus University Hospital (Scientific Director of iPSYCH): anders@humgen.au.dk; tel: 8716 7768 or 60202720
Professor Ole Mors, Aarhus University and Aarhus University Hospital: nielmors@rm.dk; tel: 7847 1166
Professor Preben Bo Mortensen, Aarhus University: pbm@ncrr.dk; tel:. 8716 5359
Professor Thomas Werge, Mental Health Services in the Capital Region of Denmark: thomas.werge@regionh.dk; tel: 4633 4968
Professor Merete Nordentoft, Mental Health Services in the Capital Region of Denmark: merete.nordentoft@regionh.dk; tel: 3531 6239.

More information: 
Anne-Marie Engel, Director of Research, the Lundbeck Foundation: ame@lundbeckfonden.com; 

tel: 3912 8000. here


picture credit

via Mad in America


Fe Fi Fo Fum, I Smell the Wiff of a Eugenics Drum! by Olga Runciman 

a brief excerpt:

"That pharmaceutical companies finance research is not new and neither is it surprising that a company whose major profits arise from psychiatric drugs would want to finance research in precisely that area. What is of interest though, is who will be doing the research, and one person is notable. A person who has created controversy in his claims of having found the genetic cause for schizophrenia and especially his statements regarding the future possibility of being able to identify and thus giving prospective parents the option of aborting ‘schizophrenic’ foetuses.

"Thomas Werge, a prominent Danish biochemist and initiator of the Danish Psychiatric Biobank hit the Danish newspapers when he along with others in a European consortium published a research paper in 2008 announcing that the genes for schizophrenia had (almost) been found. 
"Region Hovedstadens Psykiatri (Mental Health Services of the Capital Region of Denmark) announced without compunction “The Mystery of Schizophrenia Solved” a very bold statement indeed, considering they represent the psychiatric system. Interestingly, they were also the only ones to state with absolute certainty in 2008 that the mystery of schizophrenia was solved. Not only did they make this statement, but they featured an interview with Werge on his research findings, “These results give science a basis to think differently and to go new ways. We now know what we have always believed is true. The illness is a biological illness of the individual and not a reaction to a sick society as has been claimed in the 1960’s and 1970’s by anti-psychiatry. Therefore, we can for the first time contemplate biological diagnosis such as prenatal screening. This is a whole new way of thinking within this area of psychiatry and necessitates that we proceed extremely carefully and in a responsible manner.”[iii]" read here

2 comments:

Rossa Forbes said...

Did I miss something here? When I saw the name Lundbeck, my ears perked up. This is the Danish pharmaceutical company that manufactures Serdolect, the antipsychotic my son finally managed to wean himself off of. Still 1 mg of Abilify to go, and then he has to find a way to live life unmedicated.

Becky said...

The search for the genetic causes 'disease' when no disease has been identified for any of the psychiatric diagnoses mentioned. the statement, "We will identify biological disease mechanisms," is a goal that is an attempt to justify continuing the indiscriminate drugging that is disabling and killing those with psychiatric diagnoses. Gee...I wonder why Lundbeck is funding the research? NOT!

LinkWithin

Related Posts Plugin for WordPress, Blogger...

FAIR USE NOTICE: This may contain copyrighted
(C) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available for educational purposes, to advance understanding of human rights, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in Title 17 U.S.C. section 107 of the US Copyright Law. This material is distributed without profit.